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ABSTRACT: Golden Gate cloning is a prominent DNA assembly tool in
synthetic biology for the assembly of plasmid constructs often used in
combinatorial pathway optimization, with a number of assembly kits developed
speciﬁcally for yeast and plant-based expression. However, its use for synthetic
biology in commonly used bacterial systems such as Escherichia coli has surprisingly
been overlooked. Here, we introduce EcoFlex a simpliﬁed modular package of
DNA parts for a variety of applications in E. coli, cell-free protein synthesis, protein
puriﬁcation and hierarchical assembly of transcription units based on the MoClo
assembly standard. The kit features a library of constitutive promoters, T7
expression, RBS strength variants, synthetic terminators, protein puriﬁcation tags
and ﬂuorescence proteins. We validate EcoFlex by assembling a 68-part containing
(20 genes) plasmid (31 kb), characterize in vivo and in vitro library parts, and
perform combinatorial pathway assembly, using pooled libraries of either
ﬂuorescent proteins or the biosynthetic genes for the antimicrobial pigment
violacein as a proof-of-concept. To minimize pathway screening, we also introduce a secondary module design site to simplify
MoClo pathway optimization. In summary, EcoFlex provides a standardized and multifunctional kit for a variety of applications
in E. coli synthetic biology.
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A prime target for synthetic biology is the production ofnatural and commodity chemical products such as drug
precursors, ﬁne and specialized chemicals and biofuels using
renewable feedstocks.1 This is driven by the need to transition
away from a current reliance on petroleum-derived chemical
products and production processes. A more sustainable and
environmentally friendly solution to this problem is in the
application of synthetic biology to engineer enzyme bio-
synthetic pathways primarily within microbial cells to produce
such chemical products. Essential to the synthetic biology
workﬂow is the use of rapid, eﬃcient and hierarchical DNA
assembly techniques and a number of methods have been
proposed.2 One such method, Golden Gate cloning, is a
modular, combinatorial technique used for a wide spectrum of
DNA assembly applications, from the construction of simple
transcription units (TUs) to diverse biochemical pathway
libraries originally developed by Marillonnet and colleagues.3−5
Golden Gate cloning utilizes the non-palindromic Type IIS
restriction endonuclease BsaI, which cuts outside of its
recognition sequence (GGTCTCN↓NNNN), producing a
four base pair overhang. This overhang, also known as a fusion
site, can be designed to provide directional DNA part assembly.
BsaI sites are placed at both the 5′ and 3′ ends of a DNA part in
inverse orientation, allowing the restriction site to be removed
before assembly by the T4 DNA ligase. DNA parts are held
within “entry vectors” and can include promoters, protein tags,
ribosome-binding sites (RBS), open reading frames (ORF),
protein domains, TALEN repeats,6 fusion linkers and
terminators. A combined one-pot reaction of “entry vectors”
is then digested and ligated into “destination vectors” using
BsaI and T4 DNA ligase. Golden Gate assembly has been
demonstrated to assemble up to 10 DNA fragments with
greater than 95% eﬃciency5 and relies solely on the use of the
BsaI enzyme. Recently, modiﬁcations to the original Golden
Gate cloning technique included Golden Braid and MoClo
standards,7,8 which rely on the use of alternating antibiotic
marker plasmids and dual type IIS endonucleases (BsaI/BsmBI
or BsaI/BpiI) to rapidly construct hierarchical multigene
pathways up to 33 kb in size.9 In summary, several plasmid
kits have been developed including MoClo and GoldenBraid
for plants,7,10,11 Saccharomyces cerevisiae12,13 and Schizosacchar-
omyces pombe.14 For a detailed review of assembly strategies
utilizing Type IIS endonucleases please see Casini et al.2
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Focusing on MoClo, this particular assembly scheme allows
ﬂexible design of multiple transcription units into modular
pathways with each gene under the control of its own
promoter, RBS and terminator.
Until the recent release of the CIDAR MoClo kit,15 Golden
Gate assembly kits for commonly used bacterial systems such as
E. coli have surprisingly been overlooked. CIDAR focuses on an
automated workﬂow for MoClo assembly. However, we wanted
to expand this further by modifying and creating a new ﬂexible
Golden Gate toolkit speciﬁcally for E. coli synthetic biology,
based on a custom-designed modular library of standard
biological parts for hierarchical DNA assembly and optimiza-
tion, using the MoClo assembly standard.9 Herein, we present
EcoFlex, a user-friendly, characterized and customizable Golden
Gate kit with parts that can be used for example in
combinatorial pathway optimization, cell-free circuit design,
recombinant protein puriﬁcation and, in the future, genome
engineering. We have also included a custom-designed library
of constitutive σ70 promoters, inducible expression based on the
T7 RNA polymerase, a standardized RBS library and a range of
synthetic terminators previously characterized.16 The EcoFlex
kit also provides options for recombinant protein production
and puriﬁcation, such as N-terminal linkers for hexahistidine
and Strep(II)-tag puriﬁcation, with either constitutive or T7-
inducible expression as single parts or combined with a T7
promoter, RBS, His6-tag and thrombin cleavage site. We also
provide a plasmid cassette system (and individual parts) for
inducible T7 RNA polymerase (RNAP) production and
puriﬁcation (Figure S6). We validate T7 RNAP activity using
cell-free protein synthesis (CFPS). We have also made two
improvements to the MoClo system, ﬁrst by simplifying the
storage plasmid for open reading frames (ORFs), and second
we introduce a secondly site to oﬀer ﬂexibility in pathway
design. For example, three TUs can be placed in the secondary
module under constant expression, while the primary site can
be used to assemble and optimize a speciﬁc gene, regulatory
cascade or biosynthetic pathway.
In synthetic biology, there is an increasing need to provide a
repertoire of biological parts (promoters, RBS, terminators)
characterized in the context of the chosen DNA assembly
technique. For example, DNA parts can behave diﬀerently
when placed in a diﬀerent context (known as “context
dependency”), which directly challenges the engineering
dogma surrounding synthetic biology. A number of inves-
tigators have tried to address this problem through the design
of neutral insulator sequences.17−19 To understand such eﬀects
in our EcoFlex kit, we have validated our library of biological
parts both in vivo and in vitro (in cell-free reactions). To
demonstrate the broad utility of EcoFlex, we also provide
exemplars of rapidly assembling and purifying His6-tagged
proteins, rational library design using ﬂow cytometry and the
optimization of the violacein biosynthetic pathway using a
secondary MoClo module to simplify pathway design and
increase the frequency of successful library assemblies.
E. coli is one of the major workhorses in synthetic biology,
providing a very well-studied chassis for the manipulation of
genetic circuits and implementation of biosynthetic pathways.
Using a repertoire of biological parts, modular DNA pathways
can be eﬃciently assembled using a range of techniques such as
Golden Gate assembly,3 BglBricks,20 AQUA,21 BASIC22 and
unique nucleotide sequence (UNS)-guided assembly.23 In
addition, other cloning methods include PCR and restriction
enzyme-based cloning, Gibson assembly24 and sequence-
ligation independent cloning.25 Eventually we desire to
assemble a universal cloning system based on the MoClo
standard for prokaryotic host expression to allow an ORF or
DNA part (e.g., promoter, RBS) to be easily portable between
multiple systems. To begin building this foundation, we reveal
EcoFlex that is designed to provide users a ﬂexible
combinatorial library toolbox that can also be customized for
variety of synthetic biology applications in E. coli.
We have built a versatile Golden Gate toolbox based on the
MoClo assembly standard9 for E. coli synthetic biology, which
we make available through AddGene (www.addgene.org/
cloning/moclo/freemont-ecoﬂex). To design this kit, we
focus on providing ﬂexibility and compatibility with a variety
of applications such as pathway assembly, cell-free protein
synthesis (CFPS) and recombinant protein puriﬁcation (Figure
1). Promoters, RBS, tags, ORFs and terminator “parts” were
assembled and stored in Level 0 “entry vectors” with
chloramphenicol resistance gene and pMB1 origin of
replication. A unique feature of our assembly kit is the “entry
vector” for storing ORFs (pBP-ORF), whereby to standardize
the cloning procedure, each gene is PCR cloned into NdeI and
BamHI sites, which are ﬂanked by inverse BsaI sites for Golden
Gate assembly. The NdeI (CATATG) site provides the fusion
site (in bold) for Golden Gate assembly to the RBS sequence
(or N-terminal tag) and the start codon for each gene, so no
additional amino acids are added to the encoded protein.
Optionally, if NdeI or BamHI sites are located within the gene,
a NcoI site is also provided in the vector, while BglII, which
produces cohesive ends, can be used in place of BamHI. ORFs
can also be cloned with ﬂanking BsaI restriction sites with
compatible fusion sites (5′ CATA and 3′ TCGA). With NdeI
and BamHI cloning, these genes are also suitable for transfer
between some of the commercial pET vectors (e.g., pET-3a,
pET-14b, pET-15b) for the purpose of recombinant protein
production. Alternatively, our kit also provides customized N-
terminal fusion tags with either constitutive or T7 RNA
polymerase-dependent expression. The “entry vectors” pBP-
lacZα and pBP-ORF are customizable for assembly of new
promoter parts or ORFs. Further instructions for user
modiﬁcations are provided in the SI text.
The ﬁrst tier of assembly (Level 1) requires BsaI to assemble
monocistronic TUs, with each ORF under control of its own
unique promoter, RBS and transcription terminator (Figure
1A). This is ligated into a “destination vector” backbone
(pTU1-A, -B, -C, -D) containing a pMB1 origin and β-
lactamase gene. Level 1 fusion sites and assembly options are
summarized in Figure 1B. Level 1 TUs contain ﬂanking inverse
BsmBI sites, which are subsequently used to direct the MoClo
(Level 2) stage of assembly (ABCD). The pTU1-A, -B, -C and
-D (Level 1) plasmids allow assembly of 2−4 TUs into the
Level 2 “destination vectors” pTU2-a (to accommodate 2
TUs), -b (3 TUs) and pTU2-A, -B, -C and -D (4 TUs). In
addition, optional pTU1-D1 and pTU1-E Level 1 plasmids also
allow an additional Golden Gate fusion site for assembly up to
5 TUs in pTU2-A, -B, -C or -D. Level 2 plasmids are available
with either lacZα or RFP negative markers, a selection of
origins of replication (pMB1, ColE1 and p15A) and a
chloramphenicol resistance marker. For larger pathways, up
to 20 TUs (Figure S2) can be assembled into a Level 3
“destination vector” (pTU3-A for 2 pTU2 plasmids; pTU3-B
for 4 pTU2 plasmids).
Signiﬁcantly, we have modiﬁed the MoClo system to include
a secondary module. This is a unique feature to EcoFlex,
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whereby separate modules of Level 2 TUs (2−5 TUs) derived
from pTU2-a, -b or -A plasmids can be subcloned into a
secondary site (pTU2S-A, -a, or -b), using two compatible BpiI
sites, which is located upstream of the primary MoClo BsmBI
assembly site (Figure 1C). We have introduced this secondary
module site as an aid to minimize pathway diversity and
increase assembly eﬃciency during combinatorial optimization.
For example, instead of optimizing a six-gene pathway
randomly, one module of 2 or 3 TUs can be placed in the
secondary module, while the remaining 4 or 3 TUs,
respectively, are randomized in the primary module. This is
important since the screening technique and transformation
eﬃciency are major limiting factors for library screening. An
example of its use is demonstrated with the violacein pathway
(see below). Finally, all EcoFlex “destination vectors”
mentioned (pTU1, pTU2 and pTU3) also contain a
monomeric red ﬂuorescence protein (RFP) gene (except
pTU2S-A, -a and -b due to internal BpiI sites in RFP) under a
LacI- and CAP-sensitive promoter and strong RBS, sourced
from the iGEM Registry of standard biological parts
(BBa_J04450). The RFP transcription unit is inserted between
ﬂanking BsaI sites (for pTU1 and pTU3) or BsmBI sites (for
pTU2) so that negative colony-forming units (CFUs) can be
visibly identiﬁed (red) after plate growth.
A range of promoter and RBS strength variants were created
by randomizing the E. coli σ70 Anderson promoter collection26
and PET RBS Shine-Dalgarno consensus sequences, respec-
tively, upstream of a eGFP (hereafter referred to as GFP)
ﬂuorescence reporter with ﬂanking BsaI sites provided for
downstream Golden Gate Level 1 assembly (see SI text). We
utilized the iGEM Anderson promoters J23100, J23108 and
J23114 as internal reference standards. For the RBS library a 6
bp Shine-Dalgarno consensus sequence AGGAGA was
randomized to RRRRRR (A/G) to vary ribosome binding
strength and a range of low-high strengths are provided. The
promoter and RBS strengths in Level 1 context were
characterized in the destination vector pTU1-A with a constant
J23100/SJM901 promoter (RBS library) or PET RBS
(promoter library), GFP and BBa_B0015 terminator. This
was performed using E. coli as a chassis with in vivo or in vitro
(CFPS) ﬂuorescence measurements. Previously we have
demonstrated a link between in vivo and in vitro character-
ization of promoter and RBS activity.27 Herein, we provide
further evidence of this relationship by characterizing a wider
range of promoter (Figure 2A,E), RBS (Figure 2B) and
synthetic terminator parts (Figure 2C,D).
In summary, most of the parts behaved similarly between the
two systems. For example, a strong promoter or terminator in
vivo was generally strong in vitro. However, there are some
exceptions to this general rule. For example, in vivo, the SJM901
promoter variant showed a moderate GFP synthesis rate of 1.2-
fold in comparison to the J23100 promoter standard.
Unexpectedly, in vitro, this rate increased to 7.8-fold (Figure
2A,E,F). While promoter strengths demonstrated a clear link
between in vivo and in vitro activity, we observed some
diﬀerences between RBS and terminator activity, which was
dependent on the strength of promoter used. Unlike in vivo, in
vitro, the signal-noise ratio for the J23100 promoter was low
(Figure S4), thus it is unclear to diﬀerentiate between weak-
strong RBS variants. This could be improved by using the
Figure 1. EcoFlex assembly. (A) Level 0 parts are held in pBP (bioparts−promoters, RBS, tags and terminators) and pBP-ORF (open reading
frames) plasmids and assembled with BsaI and T4 DNA ligase into pTU1 destination plasmids (A, -B, -C, -D or -D1, -E) forming Level 1 TUs.
Genes are cloned with NdeI (5′) and BamHI (3′), with the NdeI site providing an overlap between the start codon and RBS fusion site (CATA).
Alternatively, if these sites are located within the gene, custom designed BsaI primers are used. Level 2 modules (2−5 TUs) were assembled with
BsmBI and T4 DNA ligase into pTU2 plasmids, which were modiﬁed to provide ﬂexibility for assembling 3−5 TUs into a module. In addition, Level
3 pathways (up to 20 TUs) can be assembled from compatible Level 2 modules into pTU3-A or pTU3-B using BsaI and T4 DNA ligase. (B)
Assembly options (i) for puriﬁcation tags and promoter choice, (ii) fusion site sequences and positions for Level 1 assembly of TUs. (C) Secondary
module cloning for optimizing library screening and minimizing pathway variation. Table details compatible fusion sites and assembly options.
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strong SJM901 promoter (Figure S4). However, with the
SJM901 promoter the range of weak-strong RBS variants
indicated from in vivo observations was not as clear in vitro,
while some variants showed enhanced activity (TL2 and TL4)
of almost 3-fold over the PET standard. These ﬁndings could
suggest that the strong activity of the SJM901 promoter
saturates ribosome binding in vitro therefore narrowing the
range of observed activities for apparent weak and strong RBS
variants.
For terminator characterization, a diﬀerent assay was
designed to quantify terminator eﬃciency using EcoFlex
parts. To do this, GFP was assembled into pTU1-A with the
J23100 or SJM901 promoter and PET RBS, followed by a
variable strength terminator. In pTU1-B, mCherry was
assembled with the weak J23114 promoter, PET RBS and
BBa_B0015 terminator. These two TUs were then assembled
into pTU2-a as a Level 2 assembly (Figure S3). If the variable
terminator allowed read-through transcription, this was
Figure 2. Part characterization in vitro and in vivo. A select range of promoters (A), RBS (B) and terminator variants (C, D) were tested for relative
activity in E. coli DH10β and cell-free protein synthesis. The J23100 and PET RBS were used for normalization of promoter and RBS data,
respectively. For the terminator assay (Level 2 plasmids), GFP was assembled with a SJM901 promoter, PET RBS and a variable strength terminator.
This was followed by a weak J23114 promoter, PET RBS, mCherry and BBa_B0015 terminator. Terminator data is represented as normalized
relative activity of GFP and mCherry, respectively. (E) The Sigma70 promoter library characterization using cell-free protein synthesis. (F) Visual
appearance of GFP production from cell-free extracts with the SJM901 promoter in comparison to J23100.
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detected by mCherry ﬂuorescence. In comparison to the
original publication describing the synthetic terminator parts16
used herein, the simple assay we utilize diﬀers in the use of a
strong constitutive promoter instead of the arabinose induction
system used previously.16 We represent our data as a mCherry
and GFP rate that is normalized to a control plasmid containing
two strong BBa_B0015 terminators for both GFP and mCherry
(Figure 2C,D). Although our data is not a direct comparison to
Chen et al.,16 our in vivo measurements suggest that the activity
of the synthetic terminators is reproducible in the EcoFlex
context with either the SJM901 (Figure 2C) and J23100
promoters (see SI ﬁles). It should also be noted that growth
rate of the Level 2 plasmids (chloramphenicol) is considerably
slower than for the promoter and RBS characterization data,
where Level 1 plasmids (carbenicillin) are used. The standard
error of the growth and GFP rates also increases signiﬁcantly by
utilizing the stronger SJM901, which is not apparent from the
original Level 1 promoter characterization. Interestingly, by
using the J23100 promoter this error decreases, suggesting that
the SJM901 promoter causes more stress to the cells in Level 2
plasmids. We utilized both promoters, since for cell-free
measurements, only the stronger SJM901 promoter was
suﬃcient to drive production of mCherry.
With the SJM901 promoter in vivo, the strongest terminators
were L3S2P21 (0.37-fold mCherry rate), L3S1P51 (0.73-fold),
L3S1P32 (1.26-fold) and L3S1P11 (1.98-fold), each showing a
low rate of mCherry ﬂuorescence in comparison to the strong
BBa_B0015 terminator. The remaining library members show a
3 to 10-fold increased mCherry ﬂuorescence rate. The signal
intensity of GFP varied between the constructs but remained
within a 2.5-fold range of the BBa_B0015 control plasmid.
Interestingly, for all of the strong terminators observed in vivo,
these also behaved similarly in vitro (Figure 2D). However, of
the weaker terminators only L2U5H1 (2.88) and BBa_B0012
(3.09) showed a clear increase in relative mCherry signal. We
did observe a broad range of activities, suggesting that small
changes in the terminator structure can have signiﬁcant eﬀects
on either GFP or mCherry production. Mechanisms outlined
by Chen et al.16 can include changes in mRNA degradation,
sequestering of the mCherry RBS site through complex
secondary structure or decreased translation coupling. Through
continued study and a broader in depth characterization of
DNA parts for EcoFlex, the changes we have observed could be
minimized by implementing the method of Mutalik et al.18 or
introducing neutral insulator DNA sequences17−19 to minimize
complex mRNA secondary structure.
ORFs can be fused to a N-terminal fusion tag such as
Strep(II) or His6-tag for recombinant protein production and
puriﬁcation. In addition, a combined T7 promoter, PET RBS,
His6-tag and thrombin cleavage site can be fused to an ORF of
interest, terminator and “destination vector” (e.g., pTU1-A-
RFP) as a four-part assembly and transformed directly into a
lysogenic DE3 strain such as BL21 Gold or KRX for IPTG-
inducible T7-expression. Alternatively, lower strength con-
stitutive promoters can also be used to lower protein levels to
prevent aggregation and inclusion body formation, a problem
often encountered with T7-based expression.28 In summary,
users can construct TUs rapidly with the desired combinations
of promoter strength, RBS variants, N-terminal linkers, ORFs
and terminator strength and conveniently identify correctly
assembled vectors using blue/white (LacZ) or red/white
(RFP) screening. Furthermore, for protein production, an
ORF can be assembled with EcoFlex, expressed and puriﬁed
within 48 h.
As an example, we subcloned CFP and mCherry into the
pET-15b vector using the NdeI and BamHI restriction sites. As
a comparison, the same genes were MoClo assembled into
pTU1-A with the combined T7 promoter, His6-tag and
thrombin cleavage site, together with the BBa_B0015
terminator. We then compared protein production and
puriﬁcation, using BL21 (DE3) Gold pLysS as a host strain.
In summary, in comparison to the pET-15b expression system,
our plasmid system produces equivalent levels of the
recombinant His6-tagged CFP and mCherry proteins, with a
summary of the SDS-PAGE puriﬁcation of CFP and mCherry
shown in Figure 3. To further demonstrate this system, we also
tested a variety of proteins (from our own library collection)
with this system showing high levels of production in the E. coli
KRX autoinduction strain (Figure S5, Table S4).
The assembly of random DNA part libraries for promoter,
RBS, ORF and terminator variants is a powerful technique to
explore the design space for constructing pathway combina-
tions. Using pooled libraries of promoters and RBS variants for
GFP and mCherry in pTU1-A and pTU1-B, respectively, these
two TUs were randomly assembled into pTU2-a. Three
separate libraries for both GFP and mCherry, with either 32,
52 or 102 variants (for list of parts see Table S4) for coupled
promoter and RBS combinations, were built in Level 1
plasmids, creating pTU1-A-GFP and pTU1-B-mCherry.
These pooled libraries were sequenced and combinations of
pTU1-A-GFP and pTU1-B-mCherry were assembled into
pTU2-a, therefore creating theoretical library sizes of 81 (32
variants of GFP combined with 32 variants of mCherry), 625
(52 variants of GFP combined with 52 variants of mCherry) or
10 000 (102 variants of GFP combined with 102 variants of
mCherry). The libraries were analyzed by ﬂow cytometry to
determine the relative distribution of pathway variants
expressing GFP and mCherry. The ﬂuorescence of GFP and
mCherry Level 1 (Figure S7) and Level 2 libraries (Figure 4)
was compared to individual Level 1 reference standards (Figure
S7) prepared with the J23100, J23108 and J23114 promoters,
strong PET RBS and BBa_B0015 terminator, as well as an
Figure 3. T7 protein production and His6-tag puriﬁcation of mCherry
and CFP. E. coli BL21 Gold (DE3) plasmids strains were grown at 37
°C and induced with 0.4 mM IPTG overnight at 19 °C. Recombinant
proteins were puriﬁed using IMAC gravity-ﬂow resin and washed with
increasing concentrations of imidazole. Figure abbreviations are as
follows: M, protein marker; S, soluble extract; I, insoluble proteins;
and EF, elution fraction.
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empty vector control (pTU1-A-lacZα). The population
distributions of the Level 1 and 2 libraries shifted in response
to the diversity of the libraries (Table S5) assembled in the
MoClo reactions (Table S6). In general, an increase in the
diversity of the library from 32, to 52 or 102, resulted in an
increase in diversity for populations that were compared to the
expression proﬁles of the medium (J23108) and strong
expression (J23100) proﬁles of the GFP or mCherry standards.
For instance, the population distributions of Level 1 GFP
libraries shifted toward an increase in the strong expression
proﬁle (J23100-GFP) from 4.41% (32) toward 12.3% (52) and
11% (102) and a marked decrease in the weak expression
proﬁle (J23114-GFP) from 70.9% (32) decreasing to 64.1%
(52) and 46.3% (102). Additionally, the Level 1 mCherry library
proﬁles displayed an increased representation of the medium
(J23108-mCherry) expression from 35.7% (32) toward 45.1%
(52) and 57.2% (102), as the diversity of the library was
increased.
Analysis of the Level 2 libraries has also shown that as the
library diversity was increased from 52 to 102 there was greater
representation of populations in the strong expression proﬁles
of both J23100-GFP (52: 0.68% to 102: 4.59%) and J23100-
mCherry (52: 4.14% to 102: 16.9%). The bias toward low-
expression in the smaller libraries is likely to occur during the
overnight growth phase during Level 1 MoClo assembly. E. coli
transformed with pooled libraries are likely to be subject to
selection pressures in which those cells transformed with
weaker promoter and/or RBS combinations were less
Figure 4. Flow cytometry of GFP and mCherry pooled promoter and RBS libraries. Mixed promoter, RBS libraries were assembled with GFP and
mCherry into pTU1-A and pTU1-B, respectively. Instead of picking single colonies, plasmid DNA was prepared directly from liquid culture, checked
for purity by restriction digest and sequencing. Level 1 GFP and mCherry libraries were then assembled into pTU2-a and transformed into DH10β.
Library cultures of Level 1 (Figure S7) and Level 2 were analyzed by ﬂow-cytometry using J23100, J23108 and J23114 promoter standards of GFP
(labeled as G100, G108 and G114) and mCherry (labeled as C100, C108 and C114) as a reference of relative strength to estimate population
distribution in both 32 (9 variants), 52 (25 variants) and 102 (100 variants) promoter-RBS combinations. These analyses are representative of
∼48 000 cells per sample and these data were analyzed using FlowJo (v10.1r5) software.
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burdened, in terms of their usage of cellular resources directed
to GFP and/or mCherry production, and thus grew more
quickly than those cells producing higher levels of the reporter
proteins.29 As a result, the cells that had lower rates of
ﬂuorescent reporter production were overrepresented in the
ﬁnal population. We show that as the size of the library is
increased there is likely to be more cells transformed with a
larger diversity of medium-to-strong promoter and RBS
strength combinations. Therefore, there was a greater diversity
of cells with diﬀerent levels of cellular burden and thus a greater
representation of E. coli producing higher levels of ﬂuorescent
reporter proteins in the ﬁnal population. While these selection
biases exist, this type of approach can provide a quality control
check of the eﬃciency for EcoFlex combinatorial assembly,
using ﬂuorescent reporter proteins to rationally enrich library
design.
Violacein is a violet pigment ﬁrst isolated from Chromo-
bacterium violaceum, and the pathway belongs to the
indolocarbazole biosynthetic family that utilizes L-tryptophan
as a common precursor.30 We chose the violacein pathway as a
model pathway for EcoFlex combinatorial optimization with
the secondary module, as it requires ﬁve enzymes (VioA, -B, -C,
-D and -E) encoded by the C. violaceum vioABCDE operon,
with gene sizes ranging from 576 to 2997 bp and a total size of
the synthetic operon of 7,242 bp. Herein, we utilize the
violacein pathway for optimization as the violet color produced
is a qualitative indication of pathway ﬂux during library
assembly.31
A major consideration for optimizing combinatorial pathways
is library size and the limitations of the screening technique.
Putting this into perspective, depending on the assembly level
and the number of parts included, Golden Gate assemblies
typically yield between 102 to 105 CFU per transformation.
Also, unlike the GFP and mCherry libraries described earlier, a
signiﬁcant decrease in transformation eﬃciency (approximately
100-fold) is observed with violacein pathway assembly. For
example, during a ﬁve TU Level 2 assembly of the complete
vioABECD pathway with the low-strength J23114 promoter,
Figure 5. Secondary module optimization: Violacein pathway assembly. (A) The vioA and vioE genes were assembled with the J23114 promoter,
PET RBS and BBa_B0015 terminator in pTU1-A and pTU1-B, respectively and then joined together in pTU2-a. The vioA-vioE fragment was
subcloned by BsaI into BpiI digested pTU2S-b to form a vioA-vioE secondary module. Level 1 promoter-RBS-terminator libraries of vioB (pTU1-A),
vioC (pTU1-B) and vioD (pTU1-C) were then assembled. Inset sequencing trace demonstrates purity of the library. Library mixtures (pMB1, ColE1
and p15A backbones) were assembled into pTU2S-vioA-vioE-b to complete the pathway. (B) 5 μL of assembly mixture was then transformed into 50
μL JM109 competent cells then grown overnight at 37 °C on 2YT and chloramphenicol plates. A range of white, brown (PDV, prodeoxyviolacein),
light purple and dark purple (violacein/deoxyviolacein) colored colonies were obtained (Table 1). Some of the white colonies developed a pale
purple shade after a further day of growth at 30 °C. (C) A selection ColE1 and p15A variants (in as a triplicate biological repeat) were grown in 5
mL of 2YT liquid culture for high-throughput Bugs2Bases sequencing (Source Bioscience). A number of promoter-RBS regions with insertions,
deletions or mutations are highlighted with an asterisk*. Crude violacein content was estimated by UV−Visible spectroscopy as described.39 Positive
control (PC) with all violacein genes under J23114 promoter, PET RBS and B0015 terminator. (D) Summary of sequencing results for p15A
variants showing a mixture of promoter-RBS and terminator combinations. For classiﬁcation, promoter, RBS and terminator are color coded as
strong, medium and weak based on GFP and mCherry characterization data. L32 vioD terminator could not be identiﬁed, highlighted as a question
mark. Asterisk* indicates single base-pair deletions in p15A library. For full sequencing results, please refer to Supporting Information. Sequencing
information is representative of a single culture after additional growth step performed at Source Bioscience.
ACS Synthetic Biology Letter
DOI: 10.1021/acssynbio.6b00031
ACS Synth. Biol. XXXX, XXX, XXX−XXX
G
only 20−30 purple colonies were obtained from either JM109
or KRX high eﬃciency (1 × 108 CFU per μg DNA) competent
cells. Toxicity was also noted during optimization of violacein
with VEGAS cloning in Brewer’s yeast.13 To tackle this
problem and provide an aid to debug pathway diversity toward
a more favorable design space, we decided to introduce a
secondary module site into the EcoFlex cloning scheme (Figure
1C). This secondary module encodes two BpiI sites (see SI
text), which provide compatible overhangs (5′ CTAT) and (3′
GTAC) for transferring a subpathway (or other DNA parts)
from the Level 2 plasmids pTU2-A, -a, or -b through BsaI
digest, thus allowing entry of 2−5 TUs into the secondary site.
As an example, a constant subpathway for the vioA and vioE
genes was assembled into the RFP-containing pTU1-A and -B
destination plasmids respectively, with a J23114 promoter, PET
RBS and BBa_B0015 terminator. Next, the vioA and vioE TUs
were assembled into pTU2-a, before subcloning of this module
by BsaI digest into the BpiI-linearized secondary module
plasmid pTU2S-b, creating pTU2S-vioA-vioE-b with either
pMB1 (high-copy), ColE1 (medium-copy) and p15A (low-
copy) origins of replication. Next, pooled promoter, RBS and
terminator libraries, and vioB, vioC and vioD genes were
assembled in pTU1-A-lacZα, pTU1-B-lacZα and pTU1-C-
lacZα respectively. 50 μL of the transformation mixture was
plated onto carbenicillin agar to estimate Level 1 eﬃciency
using blue/white colony screening (>99% eﬃciency), while the
remaining mixture (∼200 μL) was directly inoculated into 10
mL of LB medium (with carbenicillin) and grown overnight at
30 °C. The library plasmid DNA was isolated, veriﬁed for
homogeneity by restriction digest and sequenced (Figure 5A).
Level 1 promoter-RBS-terminator libraries of vioB, vioC and
vioD were then assembled into pTU2S-vioA-vioE-b (pMB1,
ColE1 and p15A) using BsmBI and T4 DNA ligase. Five μL of
the reaction mixture was then transformed into 50 μL of E. coli
JM109 competent cells and plated onto chloramphenicol plates
and counted for CFUs (Figure 5B and Table 1). We utilized
JM109 instead of DH10β as we have observed instability issues
with complex biosynthetic pathways with DH10β. For example,
transformation of the lycopene or violacein pathway (pTU2-A-
vioABCDE − positive pathway control) yields a low percentage
of white colonies, which upon plasmid puriﬁcation yields the
same mini-prep restriction digest map as the original plasmid.
Whilst we did not pursue sequencing to identify potential
mutations, it is known that DH10β has a high basal mutation
frequency.32 With JM109 transformants, we observed a variety
of CFU phenotypes indicating production of violacein
intermediates (Table 1). Unlike the low-eﬃciency 5 TU
vioABCDE assembly, approximately 102−103 CFUs were
obtained with the plasmids containing the pMB1, ColE1 or
p15A origins of replication (Table 1).
Initially, we assayed violacein production and sequenced the
library parts around each TU (vioB, vioC and vioD) in a few
colonies from the library transformation plate with pMB1
origin, and found that most of them contain a mutated
promoter or RBS in at least one of the vioB, vioC or vioD TUs
after overnight growth (see SI text and Figure S9−10). It is also
interesting to note that some of the clones after overnight
liquid or plate growth lose their ability to produce violacein,
which is consistent with a mutation or recombination event. To
test whether this was linked to plasmid copy number, we also
screened colonies from the library transformation using ColE1
(medium-copy) and p15A (low-copy) origins of replication.
Focusing on the ColE1 and p15A plasmid variants, we
restreaked purple colonies onto fresh plates and single colonies
were then grown in biological triplicate to semi-quantify crude
violacein, while liquid culture aliquots were sent for high-
throughput 96-well sequencing (Bugs2Bases, Source Bio-
science) of the vioB, vioC and vioD library regions, which
requires an additional subculturing step before DNA
puriﬁcation and sequencing. For ColE1 plasmid variants, only
5/11 clones were absent of mutations, while for p15A clones,
this increased to 9/11 clones. However, in the two p15A clones
that did contain a mutation (L32 vioC RBS and L40 vioD
promoter), these were single base-pair deletions immediately
adjacent to the MoClo fusion site and could be derived from
initial Level 1 assembly (Figure S13). In addition, the
sequencing trace of the L32 vioD terminator was weak, despite
repeat sequencing. The impact of the violacein pathway as a
strong negative selection marker also appeared to amplify the
frequency of these mutation events. Golden Gate and MoClo
assembly is renowned to be highly eﬃcient and a restriction
digest of DNA is generally considered acceptable for quality-
control checking.33 In contrast, the mutations found in pMB1
and ColE1 variants generally represent deletions (probable
recombination events), which form spontaneously during
subculturing. We speculate that these events are due to
repetitive promoter, RBS and terminator sequences16,34 used
during assembly, and strong selection pressures caused by
violacein production. This is further supported by the fact that
no mutations or deletions were detected within the sequenced
regions of the vioB, vioC and vioD ORFs, thus mutations only
seemed to occur within the promoter, RBS or terminator
sequences. This provides a strong focal point for improvement
in our future studies of library design. Please see Supporting
Information for a full summary of these ﬁndings.
In general, the library colonies gave a wide range of crude
violacein yields, with the highest producing strain L15 giving
66.3 ± 5.6 mg L−1 and the lowest strain L21 giving 3.6 ± 1.7
mg L−1 (Figure 5D). However, the ColE1 positive control
strain (with all violacein genes under J23114 promoter, PET
RBS and BBa_B0015 terminator) had the highest crude
violacein yield at 69.1 ± 7.4 mg L−1, whereas the equivalent
p15A positive control strain produced 9.9 ± 1.3 mg L−1, the
lowest among the p15A library strains (Figure 5). From the
sequencing information, the ColE1 and p15A libraries were
predominated by weak-medium strength promoters and a range
of RBS combinations. Interestingly, the strongest promoter
library member SJM901 appears in two instances with vioC, but
it was only found in the p15A variants. It should also be noted
that when violacein production was previously optimized with
ePathOptimize using ﬁve engineered variants of the T7
promoter, all strong producing clones (up to 60−240 mg L−1
crude violacein) were predominated by combinations of the
weakest T7 promoter variant.35 Although our study only used
constitutive promoters, the frequent occurrence of weak
promoters with strong pathway variants is a shared common
Table 1. CFUs for Violacein Pathway Optimization with the
Secondary Module
CFU phenotypes
origin of replication violacein (high) violacein (low) PDV white
pMB1 (high) 27 7 18 48
ColE1 (medium) 88 6 57 115
p15A (low) 270 0 118 154
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theme between these two studies. Fine-tuning of violacein ﬂux
was also recently examined by rationally minimizing library size
of RBS sites in a recent study.36
For the terminators, there was a strong bias toward the
L3S2P21, L2U5H08, L2U2H08 and Bba_B0015 members with
only a single occurrence of Bba_B0012. Considering all variants
of the EcoFlex library were included at approximately the same
concentration at the initial Level 1 assembly, it is still unclear
why certain terminators become more frequent at the ﬁnal
stage of selection of violacein CFUs.
While the EcoFlex kit is primarily designed for E. coli, we are
also interested in expanding this toolkit toward a universal
cloning system between alternative prokaryotic hosts that oﬀer
attractive advantages in biotechnology, such as thermophilic
growth, utilization of alternative carbon feedstocks, resistance
to growth-inhibitory metabolites and high titer natural product
synthesis. For example, a pathway design could be studied in a
non-traditional host and an individual gene from the same
pathway could then be rapidly swapped into E. coli for enzyme
or structural studies. Furthermore, while we demonstrate that
the secondary module can be used for the optimization of
biosynthetic pathways, this feature could also be used for
constructing novel shuttle vectors or genome engineering tools.
EcoFlex provides a foundation for the design and implementa-
tion of a universal cloning system as we look toward arcane
chassis,37 which are becoming increasingly important for future
synthetic biology directions. In summary, the EcoFlex kit
provides a simpliﬁed cloning scheme that can be used for a
variety of synthetic biology applications for E. coli and, in the
future, alternative prokaryotic host systems.
■ METHODS
Bacterial Strains and Growth. Routine bacterial growth
was performed at 37 °C in LB broth, with agar (15 g L−1),
carbenicillin (100 μg mL−1), kanamycin (50 μg mL−1) or
chloramphenicol (35 μg mL−1) as needed. Chemically
competent E. coli DH10β (NEB), JM109 (Promega) and
KRX (Promega) were used for routine transformations and
maintenance of plasmids.
Molecular Biology. Restriction enzymes (NEB), T4
polynucleotide kinase (NEB), T4 DNA ligase (Promega),
Phusion (Agilent) and Q5 DNA polymerase (NEB) were used
for routine cloning methods. Molecular biology kits were
purchased from Qiagen (QIAprep Miniprep kit and QIAquick
gel extraction kit). Primers and the lacZα fragment (see SI text)
were synthesized by IDT. DNA parts and primer sequences are
provided in the Supporting Information. Routine and high-
throughput Bugs2Bases DNA sequencing was performed by
Source Bioscience, Cambridge.
EcoFlex Assembly Conditions. For Level 1 and 3
assembly, 100 ng of each DNA part was combined with 50
ng of destination plasmid and incubated with BsaI and T4
ligase for 15−30 cycles of 5 min at 37 °C and 10 min at 16 °C,
followed by 5 min at 50 °C and 5 min at 80 °C. For Level 2
assembly, BsmBI was used as the type IIS restriction enzyme
and the reaction was incubated at 37 °C overnight. Five μL of
Golden Gate reaction mix was transformed into 50 μL of
chemically competent E. coli DH10β, JM109 or KRX cells using
heat shock transformation. After recovery in 200 μL of SOC
medium (NEB), 50−100 μL of cells were plated onto LB
antibiotic plates and grown at 37 °C overnight. For assembly of
Level 1 libraries, a pooled library of promoters or RBS (100 ng
uL−1) variants were assembled in a Level 1 assembly reaction
and transformed into DH10β. Instead of incubating on plates,
200 μL of the SOC mixture was directly inoculated into 10 mL
of 2YT medium with antibiotic and grown overnight at 30 °C
and 160 rpm shaking. High purity library mini-preps was
veriﬁed by restriction digest and sequencing.
Flow Cytometry. Golden gate combinatorial library
reactions were transformed into E. coli and grown overnight
in 1 mL 2YT and antibiotics at 30 °C. Cell populations were
diluted into 1X phosphate buﬀered saline (2:1000) and loaded
for detection into a S3e Cell sorter (Biorad, CA, USA). GFP
detection (FL1, Excitation 488 nm, Emission 525/30 nm) and
mCherry detection (FL3, Excitation 561 nm, Emission 615/25
nm) for approximately 48 000 cells per sample, was carried out
and analyzed using FlowJo (v10.1r5) software (FlowJo, LLC,
Oregon, USA). In order to analyze the library populations, a
gating strategy was used in which reference regions were
quantiﬁed. To do this, Level 1 plasmids were prepared with
either GFP or mCherry assembled with low (J23114), low-
medium (J23108) and high (J23100) promoter strengths, the
PET RBS and BBa_B0015 terminator. Single plasmid clones
were transformed into DH10β. The distribution of library
populations was then estimated by overlapping with the known
reference standards.
Cell-Free Protein Synthesis. On the basis of the protocol
from Sun et al.,38 a cell-extract was prepared from E. coli Rosetta
(DE3) pLysS and reactions were monitored in a CLARIOStar
(BMG, Germany) plate reader. For full details, please see SI
text and Table S2.
In Vivo Growth and Fluorescence Measurements.
Promoter, RBS and terminator parts were characterized in
E. coli DH10β. Single colonies were picked in triplicate and
grown overnight at 30 °C in a 24-well plate in 2 mL of 2YT
medium with antibiotics. Cell density was measured in a
CLARIOStar plate reader at 600 nm and cells were subcultured
into 100 μL of 2YT with antibiotics in a 96-well Greiner plate
to a starting OD600 of 0.05. Plates were sealed with a Breathe-
Easy membrane (Sigma) and grown at 30 °C for 6−12 h at 600
rpm. OD600, GFP and mCherry measurements were recorded
every 10 min (see SI text). Data analysis of characterization
data was quantiﬁed as described previously with one
modiﬁcation.27 Rates of GFP and mCherry production were
quantiﬁed during exponential phase from an average of
triplicate data over a 1 h time period. For cell-free activity
measurements only, mCherry ﬂuorescence accumulates sig-
niﬁcantly later than GFP and was measured at a diﬀerent time
point.
Protein Production and Puriﬁcation. Plasmids (pET15b
or EcoFlex) were transformed into BL21 Gold (DE3) pLysS. A
10 mL 2YT overnight culture with antibiotics was grown
overnight and 0.5 mL was subcultured into 100 mL 2YT and
grown at 37 °C, 200 rpm until an OD600 of 1.0 was reached.
IPTG (0.4 mM) was added and the culture was left for 16 h at
19 °C, 200 rpm. Gravity ﬂow immobilized metal ion
chromatography (IMAC) puriﬁcation was performed. Please
see SI text for further details.
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